1. Li, Xiaoling, Wang, Yunguan, Deng, Su, Wang, Tao, Mu, Ping. 2023. Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer. In Cancer cell, 41, 1427-1449.e12. doi:10.1016/j.ccell.2023.06.010. https://pubmed.ncbi.nlm.nih.gov/37478850/
2. Herrejon Chavez, Florisela, Luo, Hanzhi, Cifani, Paolo, Vu, Ly P, Kharas, Michael G. 2023. RNA binding protein SYNCRIP maintains proteostasis and self-renewal of hematopoietic stem and progenitor cells. In Nature communications, 14, 2290. doi:10.1038/s41467-023-38001-x. https://pubmed.ncbi.nlm.nih.gov/37085479/
3. Gillentine, Madelyn A, Wang, Tianyun, Hoekzema, Kendra, Bernier, Raphael A, Eichler, Evan E. 2021. Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders. In Genome medicine, 13, 63. doi:10.1186/s13073-021-00870-6. https://pubmed.ncbi.nlm.nih.gov/33874999/
4. Khudayberdiev, Sharof, Soutschek, Michael, Ammann, Irina, Baumeister, Stefan, Schratt, Gerhard. 2020. The cytoplasmic SYNCRIP mRNA interactome of mammalian neurons. In RNA biology, 18, 1252-1264. doi:10.1080/15476286.2020.1830553. https://pubmed.ncbi.nlm.nih.gov/33030396/
5. Chen, Ying, Chan, Jingru, Chen, Wei, Yuan, Yuren Adam, Jobichen, Chacko. 2020. SYNCRIP, a new player in pri-let-7a processing. In RNA (New York, N.Y.), 26, 290-305. doi:10.1261/rna.072959.119. https://pubmed.ncbi.nlm.nih.gov/31907208/
6. Li, Chenglong, Lu, Tailiang, Chen, Hongxi, Yu, Zhige, Chen, Chaowu. 2024. The up-regulation of SYNCRIP promotes the proliferation and tumorigenesis via DNMT3A/p16 in colorectal cancer. In Scientific reports, 14, 21570. doi:10.1038/s41598-024-59575-6. https://pubmed.ncbi.nlm.nih.gov/39284825/
7. Semino, Francesca, Schröter, Julian, Willemsen, Marjolein H, Haack, Tobias B, Syrbe, Steffen. 2021. Further evidence for de novo variants in SYNCRIP as the cause of a neurodevelopmental disorder. In Human mutation, 42, 1094-1100. doi:10.1002/humu.24245. https://pubmed.ncbi.nlm.nih.gov/34157790/
智鼠故事 
